Navigation Links
Blood Markers Predict Risk for Recurrent Stroke and Mortality

People who have just suffered their first ischemic stroke, a blood clot in the brain, often have elevated inflammatory biomarkers in their blood // that indicate their likelihood of having another stroke or an increased risk of dying, according to Columbia University Medical Center researchers at NewYork-Presbyterian Hospital.

Published in the Oct. 23 Archives of Internal Medicine, results of the new study indicate that these inflammatory markers are associated with long-term prognosis after a first stroke, and may help guide clinical care for people who have suffered a first stroke.

A biomarker called lipoprotein-associated phospholipase A2 (Lp-PLA2), which has been FDA-approved to predict the risk of first stroke, was found to be a strong predictor of recurrent stroke risk. Researchers also found that elevated levels of another biomarker called high-sensitivity C-reactive protein (hs-CRP), a test commonly used to predict risk of heart disease, was associated with more severe strokes and an increased risk of mortality.

“A better understanding of biomarkers for stroke risk may lead to the use of prophylactic treatments to reduce risk of people suffering debilitating strokes,” said lead author Mitchell S. V. Elkind, M.D., M.S., associate professor of Neurology at Columbia University College of Physicians and Surgeons and neurologist at NewYork-Presbyterian. “For example, statins appear to lower these biomarker levels, so our next step may be to study the clinical benefit of prescribing statins to reduce the risk of stroke in people with elevated biomarkers, and also to treat people who have suffered a stroke so that they do not have another serious event.”

The research was conducted by taking blood samples from 467 patients who had just suffered their first ischemic stroke, from the Northern Manhattan Stroke Study, a long-term prospective study among people from the Washington Heights neighborhood in Northern Manhattan a nd the surrounding area. The ongoing study, which began in 1990, is run by the Neurological Institute of New York at Columbia University Medical Center and NewYork-Presbyterian, located in Washington Heights.

Source-Newswise
RM
'"/>




Related medicine news :

1. Recommendations for Treatment of Blood Pressue
2. Blood Cells Capable of Regenerating Liver
3. Blood clots likely in long travel
4. Hemochromatosis Patients Blood is Safe
5. Blood transfusions beneficial after heart attacks
6. Blood Pressure Drug may slow wasting in burn victims
7. Levels Of Blood Proteins May Help Heart Disease Care
8. Blood test may identify ovarian cancer
9. A Blood test for suicide risk?
10. Blood Pressure Drugs maintain muscle strength
11. Blood test diagnoses heart failure in short time
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/26/2016)... N.J. (PRWEB) , ... June 27, 2016 , ... Quality ... sources, yet in many ways they remain in the eye of the beholder, according ... (EBO), a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
Breaking Medicine Technology: